USD 0.07
(0.43%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 322.4 Thousand USD | -21.46% |
2022 | 410.47 Thousand USD | -18.39% |
2021 | 502.96 Thousand USD | -49.29% |
2020 | 991.89 Thousand USD | 40.43% |
2019 | 706.3 Thousand USD | 3046.13% |
2018 | 22.45 Thousand USD | -58.91% |
2017 | 54.63 Thousand USD | -34.81% |
2016 | 83.81 Thousand USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 11 Thousand USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 5.65 Million USD | -7.53% |
2004 | 6.11 Million USD | 4428.52% |
2003 | 135 Thousand USD | 0.0% |
2002 | 135 Thousand USD | 440.0% |
2001 | 25 Thousand USD | -70.59% |
2000 | 85 Thousand USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | -100.0% |
1997 | 48.67 Thousand USD | 0.0% |
1996 | - USD | 0.0% |
1995 | - USD | 0.0% |
1994 | - USD | 0.0% |
1993 | - USD | 0.0% |
1992 | - USD | 0.0% |
1991 | - USD | 0.0% |
1990 | - USD | 0.0% |
1989 | - USD | -100.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 FY | 322.4 Thousand USD | -21.46% |
2023 Q4 | 343.92 Thousand USD | -6.1% |
2023 Q2 | 388.33 Thousand USD | -5.39% |
2023 Q1 | 410.47 Thousand USD | -4.51% |
2023 Q3 | 366.27 Thousand USD | -5.68% |
2022 Q4 | 429.87 Thousand USD | -4.69% |
2022 Q3 | 451.04 Thousand USD | -2.83% |
2022 Q2 | 464.19 Thousand USD | -7.71% |
2022 Q1 | 502.96 Thousand USD | -3.88% |
2022 FY | 410.47 Thousand USD | -18.39% |
2021 Q4 | 523.26 Thousand USD | -24.33% |
2021 Q3 | 691.49 Thousand USD | -14.5% |
2021 Q2 | 808.77 Thousand USD | -18.46% |
2021 Q1 | 991.89 Thousand USD | 27.93% |
2021 FY | 502.96 Thousand USD | -49.29% |
2020 Q4 | 775.34 Thousand USD | -9.51% |
2020 Q2 | 620.63 Thousand USD | -12.13% |
2020 Q1 | 706.3 Thousand USD | 14.54% |
2020 FY | 991.89 Thousand USD | 40.43% |
2020 Q3 | 856.86 Thousand USD | 38.06% |
2019 Q4 | 616.65 Thousand USD | -33.17% |
2019 Q2 | 854.4 Thousand USD | 3705.8% |
2019 Q3 | 922.76 Thousand USD | 8.0% |
2019 Q1 | 22.45 Thousand USD | -26.39% |
2019 FY | 706.3 Thousand USD | 3046.13% |
2018 Q2 | 46.59 Thousand USD | -14.73% |
2018 FY | 22.45 Thousand USD | -58.91% |
2018 Q3 | 38.54 Thousand USD | -17.27% |
2018 Q4 | 30.49 Thousand USD | -20.88% |
2018 Q1 | 54.63 Thousand USD | -12.84% |
2017 Q2 | 78.77 Thousand USD | -6.01% |
2017 FY | 54.63 Thousand USD | -34.81% |
2017 Q1 | 83.81 Thousand USD | -8.16% |
2017 Q3 | 70.42 Thousand USD | -10.6% |
2017 Q4 | 62.68 Thousand USD | -10.99% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | 91.26 Thousand USD | 0.0% |
2016 FY | 83.81 Thousand USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q1 | 11 Thousand USD | -28.34% |
2010 FY | - USD | -100.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | -100.0% |
2010 Q2 | 6650.00 USD | -39.55% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q3 | 19.7 Thousand USD | 0.0% |
2009 FY | 11 Thousand USD | 0.0% |
2009 Q4 | 15.35 Thousand USD | -22.08% |
2008 Q3 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 Q2 | 5.81 Million USD | 2.81% |
2006 Q1 | 5.65 Million USD | 11.55% |
2006 FY | - USD | -100.0% |
2006 Q4 | - USD | -100.0% |
2006 Q3 | 5.97 Million USD | 2.76% |
2005 FY | 5.65 Million USD | -7.53% |
2005 Q1 | 6.11 Million USD | 62.05% |
2005 Q2 | 5.8 Million USD | -5.06% |
2005 Q3 | 3.73 Million USD | -35.58% |
2005 Q4 | 5.06 Million USD | 35.53% |
2004 Q4 | 3.77 Million USD | 33.66% |
2004 FY | 6.11 Million USD | 4428.52% |
2004 Q1 | 135 Thousand USD | 0.0% |
2004 Q2 | 135 Thousand USD | 0.0% |
2004 Q3 | 2.82 Million USD | 1990.74% |
2003 Q4 | 135 Thousand USD | 0.0% |
2003 FY | 135 Thousand USD | 0.0% |
2003 Q2 | 135 Thousand USD | 0.0% |
2003 Q1 | 135 Thousand USD | 0.0% |
2003 Q3 | 135 Thousand USD | 0.0% |
2002 Q2 | 10 Thousand USD | -60.0% |
2002 Q1 | 25 Thousand USD | 0.0% |
2002 FY | 135 Thousand USD | 440.0% |
2002 Q3 | 10 Thousand USD | 0.0% |
2002 Q4 | - USD | -100.0% |
2001 Q3 | - USD | 0.0% |
2001 Q2 | - USD | -100.0% |
2001 Q1 | 85 Thousand USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 FY | 25 Thousand USD | -70.59% |
2000 Q2 | - USD | 0.0% |
2000 FY | 85 Thousand USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 Q2 | - USD | -100.0% |
1998 Q3 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 FY | - USD | -100.0% |
1998 Q1 | 48.67 Thousand USD | 0.0% |
1997 Q2 | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
1997 FY | 48.67 Thousand USD | 0.0% |
1997 Q1 | - USD | 0.0% |
1997 Q3 | - USD | 0.0% |
1996 Q4 | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1996 Q1 | - USD | 0.0% |
1996 Q2 | - USD | 0.0% |
1996 Q3 | - USD | 0.0% |
1995 Q1 | - USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1995 Q4 | - USD | 0.0% |
1995 FY | - USD | 0.0% |
1994 Q1 | - USD | 0.0% |
1994 Q2 | - USD | 0.0% |
1994 FY | - USD | 0.0% |
1994 Q3 | - USD | 0.0% |
1993 Q1 | - USD | 0.0% |
1993 FY | - USD | 0.0% |
1993 Q2 | - USD | 0.0% |
1993 Q3 | - USD | 0.0% |
1993 Q4 | - USD | 0.0% |
1992 Q2 | - USD | 0.0% |
1992 Q3 | - USD | 0.0% |
1992 Q4 | - USD | 0.0% |
1992 FY | - USD | 0.0% |
1992 Q1 | - USD | 0.0% |
1991 Q3 | - USD | 0.0% |
1991 FY | - USD | 0.0% |
1991 Q4 | - USD | 0.0% |
1991 Q2 | - USD | 0.0% |
1991 Q1 | - USD | 0.0% |
1990 FY | - USD | 0.0% |
1990 Q1 | - USD | 0.0% |
1990 Q3 | - USD | 0.0% |
1989 Q1 | 100 Thousand USD | 0.0% |
1989 FY | - USD | -100.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Avitar, Inc. | 3.89 Million USD | 91.726% |
BioElectronics Corporation | 12.52 Million USD | 97.427% |
CVR Medical Corp. | - USD | -Infinity% |
IR-Med Inc. | 161 Thousand USD | -100.25% |
Medical Supply International USA, Inc. | 116.05 Thousand USD | -177.803% |
Polarean Imaging plc | 74.84 Thousand USD | -330.754% |
AVITA Medical, Inc. | 449.48 Thousand USD | 28.273% |
Manhattan Scientifics, Inc. | - USD | -Infinity% |
Össur hf. | 311.8 Million USD | 99.897% |
Zecotek Photonics Inc. | - USD | -Infinity% |
QHSLab, Inc. | - USD | -Infinity% |
Wellstar International, Inc. | 18.86 Million USD | 98.291% |
Össur hf. | 311.8 Million USD | 99.897% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 618 Thousand USD | 47.831% |
Escalon Medical Corp. | 279.4 Thousand USD | -15.389% |
Aurora Spine Corporation | 1.59 Million USD | 79.746% |
BrainsWay Ltd. | 239 Thousand USD | -34.896% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | - USD | -Infinity% |
Hamilton Thorne Ltd. | 16.7 Million USD | 98.07% |
Vivos Inc. | - USD | -Infinity% |
MicroPort Scientific Corporation | 814.21 Million USD | 99.96% |
Kelyniam Global, Inc. | 217.61 Thousand USD | -48.155% |
REMSleep Holdings, Inc. | 43.67 Thousand USD | -638.167% |
CYduct Diagnostics, Inc. | 590 Thousand USD | 45.356% |
Nanomix Corporation | 10.11 Million USD | 96.812% |
Theraclion SA | 1.95 Million EUR | 83.473% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 304.6 Thousand USD | -5.844% |
Positron Corporation | - USD | -Infinity% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 150 Thousand USD | -114.935% |
Lombard Medical, Inc. | 28.02 Million USD | 98.85% |
ALR Technologies Inc. | - USD | -Infinity% |
Stratec SE | 89.25 Million USD | 99.639% |
Vycor Medical, Inc. | 243.28 Thousand USD | -32.519% |
Heart Tronics, Inc. | - USD | -Infinity% |
Nu-Med Plus, Inc. | - USD | -Infinity% |
Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -126.519% |
SANUWAVE Health, Inc. | 492 Thousand USD | 34.471% |
VMS Rehab Systems, Inc. | 106.45 USD | -302767.074% |
Guided Therapeutics, Inc. | 511 Thousand USD | 36.908% |
Ingen Technologies, Inc. | 532.27 Thousand USD | 39.43% |
Odyssey Group International, Inc. | - USD | -Infinity% |
United American Healthcare Corporation | - USD | -Infinity% |
ECGI Holdings, Inc. | 804 Thousand USD | 59.9% |
Capital Group Holdings, Inc. | - USD | -Infinity% |
Urologix, Inc. | 4.58 Million USD | 92.97% |
Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 25.064% |
Nexeon MedSystems Inc. | 2.78 Million USD | 88.429% |
SS Innovations International, Inc. | 1.91 Million USD | 83.124% |
Qualis Innovations, Inc. | - USD | -Infinity% |
Smith & Nephew plc | 2.17 Billion USD | 99.985% |
NIOX Group Plc | 500 Thousand USD | 35.52% |
Fuse Medical, Inc. | 200 Thousand USD | -61.201% |
Broncus Holding Corporation | 1.22 Million USD | 73.66% |
Brain Scientific Inc. | 7378.00 USD | -4269.775% |
Pressure BioSciences, Inc. | 161.86 Thousand USD | -99.181% |
Health Logic Interactive Inc. | - USD | -Infinity% |